This Article Full Text Full Text (PDF) All Versions of this Article: 90/4/2198    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haiman, C. A. Articles by Le Marchand, L. Search for Related Content PubMed PubMed Citation Articles by Haiman, C. A. Articles by Le Marchand, L. Related Collections Female Endocrinology

Common Genetic Variation in the Sex Steroid Hormone-Binding Globulin (SHBG) Gene and Circulating SHBG Levels among Postmenopausal Women: The Multiethnic Cohort

Department of Preventive Medicine, Keck School of Medicine, University of Southern California (C.A.H., S.E.R., V.W.S., D.V.C.), Los Angeles, California 90089; Broad Institute of Massachusetts Institute of Technology and Harvard (M.L.F.), Cambridge, Massachusetts 02139; Departments of Medicine, Molecular Biology, and Hematology/Oncology, Massachusetts General Hospital (M.L.F.), Boston, Massachusetts 02114; and Etiology Program, Cancer Research Center of Hawaii, University of Hawaii (L.L.M.), Honolulu, Hawaii 96813

Address all correspondence and requests for reprints to: Dr. Christopher Haiman, University of Southern California/Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Los Angeles, California 90089. E-mail: haiman{at}usc.edu.

SHBG transports sex steroid hormones in the blood, and levels in humans are thought to partially be genetically determined. Recently, studies have found a pentanucleotide (TAAAA)_n repeat polymorphism in the promoter of the SHBG gene and a missense polymorphism in exon 6 (Asp³²⁷Asn) to predict circulating SHBG levels. Based on the potential role of common genetic variation in SHBG to serve as a marker of SHBG levels in the general population, we evaluated the association between the (TAAAA)_n repeat polymorphism, Asp³²⁷Asn polymorphism, and SHBG levels in a population of African-American, Native Hawaiian, Japanese, Latina, and white healthy postmenopausal women from the Multiethnic Cohort Study (n = 372). Mean SHBG levels were not significantly different between carriers and noncarriers of the Asn³²⁷ allele [minor allele frequency range across ethnic groups, 0.02–0.14; Asp/Asn and Asn/Asn genotypes, 33.6 mol/liter; 95% confidence interval (CI), 28.2–40.0; n = 49; Asp/Asp genotype, 30.8 mol/liter (95% CI, 28.7–33.1; n = 296); P = 0.37]. For the repeat polymorphism, we observed six different SHBG repeat alleles segregating in the population (TAAAA_6–11), and the distribution of these alleles varied widely across populations. We found suggestive evidence of linkage disequilibrium between the Asn³²⁷ allele and the eight-repeat allele in all populations except African-Americans (P 0.08). In analysis of the repeat polymorphism, SHBG levels among carriers of two short alleles (seven or fewer repeats; 31.2 nmol/liter; 95% CI, 27.3–35.6; n = 82) were not statistically different from those of carriers of two long alleles (more than seven repeats; 32.7 nmol/liter; 95% CI, 29.4–36.3; n = 124; P = 0.59). We did, however, observe individual genotypic classes (n = 16) to contribute modestly to the overall prediction of SHBG levels (by analysis of covariance, P = 0.03). Carriers of the six-repeat allele (27.9 nmol/liter; 95% CI, 25.2–30.8; n = 147) were found to have nominally significantly lower SHBG levels than noncarriers (32.4 nmol/liter; 95% CI, 29.7–35.2; n = 202; P = 0.03). This effect was stronger among the subset of women who also carried the Asn³²⁷ allele (interaction, P = 0.006). In summary, these results suggest that genetic variation at the SHBG locus may contribute to modest differences in SHBG levels among healthy postmenopausal women, and that much larger studies will be needed to better comprehend the effects of common variations at this locus in predicting circulating SHBG levels.

This article has been cited by other articles:

				A. Turk, P. Kopp, L. A. Colangelo, M. Urbanek, K. Wood, K. Liu, H. G. Skinner, and S. M. Gapstur Associations of Serum Sex Hormone Binding Globulin (SHBG) Levels with SHBG Gene Polymorphisms in the CARDIA Male Hormone Study Am. J. Epidemiol., February 15, 2008; 167(4): 412 - 418. [Abstract] [Full Text] [PDF]

				B. L. Yaspan, J. P. Breyer, Q. Cai, Q. Dai, J. B. Elmore, I. Amundson, K. M. Bradley, X.-O. Shu, Y.-T. Gao, W. D. Dupont, et al. Haplotype Analysis of CYP11A1 Identifies Promoter Variants Associated with Breast Cancer Risk Cancer Res., June 15, 2007; 67(12): 5673 - 5682. [Abstract] [Full Text] [PDF]

				S. I. Berndt, N. Chatterjee, W.-Y. Huang, S. J. Chanock, R. Welch, E. D. Crawford, and R. B. Hayes Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 165 - 168. [Abstract] [Full Text] [PDF]

				A. L. Eriksson, M. Lorentzon, D. Mellstrom, L. Vandenput, C. Swanson, N. Andersson, G. L. Hammond, J. Jakobsson, A. Rane, E. S. Orwoll, et al. SHBG Gene Promoter Polymorphisms in Men Are Associated with Serum Sex Hormone-Binding Globulin, Androgen and Androgen Metabolite Levels, and Hip Bone Mineral Density J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5029 - 5037. [Abstract] [Full Text] [PDF]

				V. W. Setiawan, C. A. Haiman, F. Z. Stanczyk, L. Le Marchand, and B. E. Henderson Racial/Ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1849 - 1855. [Abstract] [Full Text] [PDF]

				N. Xita, A. Tsatsoulis, I. Stavrou, and I. Georgiou Association of SHBG gene polymorphism with menarche Mol. Hum. Reprod., June 1, 2005; 11(6): 459 - 462. [Abstract] [Full Text] [PDF]